Abstract
Potential Long-Term Economic Benefits of Switching From Epoetin Alfa to Hypoxia-Inducible Factor Prolyl Hydroxylase (HIF-PH) Inhibitors for the Management of Anemia in Hemodialysis (HD) Patients
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
